Antibody reactivity of a standardized human serum protein solution against a spectrum of microbial pathogens and toxins: Comparison with fresh frozen plasma

Therapeutic Apheresis

Volumn 6, Issue 2, 2002, Pages 145-153

  Schmidt, Herbert ^a   Lissner, Reinhard ^b   Struff, Wilhelm ^b   Thamm, Oliver ^b   Karch, Helge ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b BIOTEST AG   (Germany)

Author keywords

Antibody reactivity; Biseko; Fresh frozen plasma; Human serum protein; Microbial pathogens

Indexed keywords

FRESH FROZEN PLASMA; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTEINASE; SHIGA TOXIN; TOXIN;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CAMPYLOBACTER JEJUNI; CANDIDA ALBICANS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; ENTEROBACTER SAKAZAKII; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMAN; KLEBSIELLA PNEUMONIAE; NEISSERIA GONORRHOEAE; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SERUM; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PNEUMONIAE;

ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; BLOOD PROTEINS; BLOOD-BORNE PATHOGENS; FUNGAL PROTEINS; HUMANS; PLASMA; PLASMA EXCHANGE; SOLUTIONS; TOXINS, BIOLOGICAL; VIRULENCE;

EID: 0036256902     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2002.00347.x     Document Type: Article

References (29)

1. Comparison of fresh frozen plasma (FFP) with a standardized serum protein solution (Biseko) following membrane plasma separation
2. Plasmapheresis in the treatment of Amanita phalloides poisoning: II. A review and recommendations
3. Plasmapheresis
4. Plasmapherese, immunsuppression und hochdosierte igG-gaben bei chronischem Guillain-Barré-Syndrom und antikörpern gegen peripheres nervengewebe
5. Plasmapheresis with a substitution solution of human serum protein (5%) versus plasmapheresis with a substitution solution of human albumin (5%) in patients suffering from autoimmune diseases
6. Serum preserve as a replacement fluid for plasma exchange therapy
7. Fresh-frozen plasma: Indications and risks
8. Viral contamination of plasma preparations
9. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples
10. Purification and biological properties of Escherichia coli verocytotoxin
11. Bactericidal properties of Campylobacter jejuni-specific immunoglobulin M antibodies in commercial immunoglobulin preparations
12. Characterization of two post-translationally processed forms of human serum retinol-binding protein: Altered ratios in chronic renal failure
13. Immunglobulinmangel nach wiederholter Plasmapherese
14. Association between Campylobacter infection and Guillain-Barré syndrome
15. Campylobacter jejuni: An emerging foodborne pathogen
16. Treatment of Guillain-Barré syndrome with intravenous immunoglobulin
17. Treatment of the adult Guillain Barré syndrome: Indications for plasma exchange
18. In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis
19. Nosocomial vancomycin resistant enterococci (VRE) in the United States, 1989-1995: The first 1000 isolates
20. Glykopeptidresistente enterokokken: Zur situation in Deutschland
21. Chlamydia pneumoniae and atherosclerosis
22. Mögliche auslöser der multiplen sklerose
23. Hemolytic-uremic syndrome and enterohemorrhagic Escherichia coli
24. Evaluation of immunoglobulin A1 (IgA1) protease and IgA1 protease-inhibitory activity in human female genital infection with Neisseria gonorrhoeae
25. Inhibition of Prevotella and Capnocytophaga immunoglobulin A1 proteases by human serum
26. Inhibition of bacterial IgA proteases by human secretory IgA and serum
27. Primary cultures of rat heaptocytes as a model system of canalicular development, biliary secretion, and intrahepatic cholestasis